Search

everythinglearnresearchcommunity

for

Search:↓

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Individualized treatments may help manage Dercum's disease symptoms.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Baricitinib was effective in treating both early and late onset alopecia areata.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Improper steroid use can cause skin issues like rosacea, which may improve after stopping the steroid and using benzoyl peroxide.

The rash resolved after stopping ponatinib.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.

Testing hair roots with a special dye is a simple, non-invasive way to check disease progress in pemphigus vulgaris patients.

Immunological treatment improved both neuropathy and alopecia.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.